Patterson-UTI's stock soared 5.02% during intraday trading on Friday, driven by positive analyst actions that boosted investor sentiment.
Susquehanna raised its price target on Patterson-UTI to $10 from $8 while maintaining a Positive rating on the shares. RBC Capital also maintained a Buy rating on the stock with a price target of $9.00, and separately raised its price target to $9 from $8 while keeping an Outperform rating.
These analyst upgrades reflect growing optimism about Patterson-UTI's prospects, with the company receiving overweight ratings and price target increases from multiple financial institutions.